PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors

Clinical trial NCT05357196 · UNKNOWN

Trial details

NCT number: NCT05357196
Sponsor: SciClone Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2020-04-13
Primary completion: 2022-08-30
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.